Literature DB >> 7600093

Predominant affection of the blue cone pathway in Parkinson's disease.

B A Haug1, R U Kolle, C Trenkwalder, W H Oertel, W Paulus.   

Abstract

Luminance contrast sensitivity and colour contrast thresholds were determined in 26 Parkinson patients and 17 normal controls of comparable age. They were psychophysically tested with a colour monitor system. Stimuli consisted of Gaussian enveloped luminance modulated or colour modulated (protan and tritan axis) vertical sine wave gratings with a spatial frequency of 1 cycle/degree. The stimuli subtended 4 degrees in diameter. Thresholds were determined using a two alternative forced choice method. Three different experimental conditions were explored: the detectability of stationary gratings, of moving gratings at velocities of 0, 2.5 and 5.0 cycles/s, and the detectability of horizontal square wave displacement at a frequency of 5 Hz for gratings of specified contrast levels. Intergroup differences were evaluated using two-tailed t tests with Satterthwaite corrections. Consistent and significant differences between normals and patients were found for tritan stimuli in the static and both dynamic conditions, and for luminance contrast stimuli in the displacement condition. Protan stimuli were much less apt to detect differences between the groups. We conclude that the retinal deficit of dopamine in Parkinson's disease is reflected in diminished centre/surround inhibition and that these changes are primarily apparent when vision is tested along the tritan axis, because blue cones are sparsely distributed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600093     DOI: 10.1093/brain/118.3.771

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

1.  Visual-evoked potentials to onset of chromatic red-green and blue-yellow gratings in Parkinson's disease never treated with L-dopa.

Authors:  F Sartucci; Vittorio Porciatti
Journal:  J Clin Neurophysiol       Date:  2006-10       Impact factor: 2.177

2.  Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.

Authors:  T Büttner; W Kuhn; T Müller; F L Welter; J Federlein; K Heidbrink; H Przuntek
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Selective Colour Vision Deficits in Multiple Sclerosis at Different Temporal Stages.

Authors:  Neda Anssari; Reza Vosoughi; Kathy Mullen; Behzad Mansouri
Journal:  Neuroophthalmology       Date:  2019-06-19

4.  Self-perception and determinants of color vision in Parkinson's disease.

Authors:  Alexander U Brandt; Hanna G Zimmermann; Timm Oberwahrenbrock; Justine Isensee; Thomas Müller; Friedemann Paul
Journal:  J Neural Transm (Vienna)       Date:  2017-11-15       Impact factor: 3.575

5.  Schizophrenia in Translation: Why the Eye?

Authors:  Steven M Silverstein; Joy J Choi; Kyle M Green; Kristen E Bowles-Johnson; Rajeev S Ramchandran
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

6.  'Gamma' band oscillatory response to chromatic stimuli in volunteers and patients with idiopathic Parkinson's disease.

Authors:  Walter G Sannita; Simone Carozzo; Paolo Orsini; Luciano Domenici; Vittorio Porciatti; Mauro Fioretto; Sergio Garbarino; Ferdinando Sartucci
Journal:  Vision Res       Date:  2009-02-14       Impact factor: 1.886

7.  Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing.

Authors:  Y Abe; T Kachi; T Kato; Y Arahata; T Yamada; Y Washimi; K Iwai; K Ito; N Yanagisawa; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

8.  Color discrimination errors associate with axial motor impairments in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Jacob Haugen; Andrew Ridder; Vikas Kotagal; Roger L Albin; Kirk A Frey; Martijn L T M Müller
Journal:  Mov Disord Clin Pract       Date:  2017-09-08

9.  Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis.

Authors:  Rosemary Tannock; Tobias Banaschewski; David Gold
Journal:  Behav Brain Funct       Date:  2006-01-27       Impact factor: 3.759

10.  Contrast Acuity With Different Colors in Parkinson's Disease.

Authors:  Harsh V Gupta; Nan Zhang; Erika Driver-Dunckley; Shyamal H Mehta; Thomas G Beach; Charles H Adler
Journal:  Mov Disord Clin Pract       Date:  2019-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.